A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s312, 2024. DOI: 10.25251/skin.8.supp.312. Disponível em: https://skin.dermsquared.com/skin/article/view/2448. Acesso em: 15 oct. 2025.